122 related articles for article (PubMed ID: 19900562)
1. Intraoperative dynamic susceptibility contrast MRI (iDSC-MRI) is as reliable as preoperatively acquired perfusion mapping.
Ulmer S; Hartwigsen G; Riedel C; Jansen O; Mehdorn HM; Nabavi A
Neuroimage; 2010 Feb; 49(3):2158-62. PubMed ID: 19900562
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI) - Technical considerations and feasibility.
Ulmer S; Helle M; Jansen O; Mehdorn HM; Nabavi A
Neuroimage; 2009 Mar; 45(1):38-43. PubMed ID: 19100843
[TBL] [Abstract][Full Text] [Related]
3. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
4. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
[TBL] [Abstract][Full Text] [Related]
5. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
6. Comparison of perfusion MRI by flow-sensitive alternating inversion recovery and dynamic susceptibility contrast in rats with permanent middle cerebral artery occlusion.
Hofmeijer J; Schepers J; van der Worp HB; Kappelle LJ; Nicolay K
NMR Biomed; 2005 Oct; 18(6):390-4. PubMed ID: 16075409
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
[TBL] [Abstract][Full Text] [Related]
8. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
9. FAIR and dynamic susceptibility contrast-enhanced perfusion imaging in healthy subjects and stroke patients.
Hunsche S; Sauner D; Schreiber WG; Oelkers P; Stoeter P
J Magn Reson Imaging; 2002 Aug; 16(2):137-46. PubMed ID: 12203760
[TBL] [Abstract][Full Text] [Related]
10. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
Young R; Babb J; Law M; Pollack E; Johnson G
J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
[TBL] [Abstract][Full Text] [Related]
11. [Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction].
Feng XY; Liang J; Yin XD; Han X; Dong Q; Lü CZ
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):952-7. PubMed ID: 12899795
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
[TBL] [Abstract][Full Text] [Related]
13. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
[TBL] [Abstract][Full Text] [Related]
14. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T.
Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R
J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539
[TBL] [Abstract][Full Text] [Related]
15. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue.
Weber MA; Günther M; Lichy MP; Delorme S; Bongers A; Thilmann C; Essig M; Zuna I; Schad LR; Debus J; Schlemmer HP
Invest Radiol; 2003 Nov; 38(11):712-8. PubMed ID: 14566181
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
Sentürk S; Oğuz KK; Cila A
Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
[TBL] [Abstract][Full Text] [Related]
17. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
18. Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma.
Ulmer S; Liess C; Kesari S; Otto N; Straube T; Jansen O
J Neurooncol; 2009 Jan; 91(2):213-20. PubMed ID: 18807224
[TBL] [Abstract][Full Text] [Related]
19. A study paradigm allowing comparison of multiple high-resolution rCBV-maps for the examination of drug effects.
Rausch M; Gentsch C; Enz A; Baumann D; Rudin M
NMR Biomed; 2005 Jun; 18(4):260-8. PubMed ID: 15759291
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility contrast and arterial spin labeled perfusion MRI in cerebrovascular disease.
Wolf RL; Alsop DC; McGarvey ML; Maldjian JA; Wang J; Detre JA
J Neuroimaging; 2003 Jan; 13(1):17-27. PubMed ID: 12593127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]